Pages that link to "Q31025224"
Jump to navigation
Jump to search
The following pages link to Cilostazol, Not Aspirin, Reduces Ischemic Brain Injury via Endothelial Protection in Spontaneously Hypertensive Rats (Q31025224):
Displaying 25 items.
- Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives (Q26744407) (← links)
- Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCε and to Activate p44/42 MAPK in Human Aortic Endothelial Cells (Q28546598) (← links)
- Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model (Q28828290) (← links)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy (Q34368970) (← links)
- The effects of hypertension on the cerebral circulation (Q34790113) (← links)
- The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis (Q34995043) (← links)
- Neuroprotective Effects of Mitochondria-Targeted Plastoquinone and Thymoquinone in a Rat Model of Brain Ischemia/Reperfusion Injury (Q35745097) (← links)
- Nitric oxide: considerations for the treatment of ischemic stroke (Q36079329) (← links)
- Homeodomain Protein Scr Regulates the Transcription of Genes Involved in Juvenile Hormone Biosynthesis in the Silkworm (Q36324490) (← links)
- Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model (Q36404185) (← links)
- Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation (Q37060774) (← links)
- Anti-photoaging properties of the phosphodiesterase 3 inhibitor cilostazol in ultraviolet B-irradiated hairless mice (Q37147840) (← links)
- Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke. (Q37690863) (← links)
- The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage (Q38055310) (← links)
- Intracranial atherosclerosis: current understanding and perspectives (Q38205224) (← links)
- The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes (Q40225108) (← links)
- Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion (Q41025659) (← links)
- A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol (Q42656245) (← links)
- Functional deterioration of endothelial nitric oxide synthase after focal cerebral ischemia (Q42956836) (← links)
- In vitro effects of cilostazol, a phosphodiesterase 3A inhibitor, on mouse oocyte maturation and morphology (Q46959135) (← links)
- Proangiogenic functions of an RGD-SLAY-containing osteopontin icosamer peptide in HUVECs and in the postischemic brain (Q47851869) (← links)
- Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke (Q48068131) (← links)
- Prevention of Femoropopliteal In-Stent Restenosis With Cilostazol: A Meta-Analysis (Q48074390) (← links)
- Effects of chronic treatment with cilostazol, a phosphodiesterase 3 inhibitor, on female rat bladder in a partial bladder outlet obstruction model. (Q51157247) (← links)
- Cilostazol restores autophagy flux in bafilomycin A1-treated, cultured cortical astrocytes through lysosomal reacidification: roles of PKA, zinc and metallothionein 3 (Q96230593) (← links)